[Fetoscopic laser photocoagulation in twin-twin transfusion syndrome]

Secco A, Ciapponi A, Pichon-Riviere A, Augustovski F, García Martí S, Alcaraz A, Bardach A.
Record ID 32018001437
Spanish
Original Title: Fotocoagulación láser por fetoscopía en síndrome de transfusión feto-fetal
Authors' recomendations: CONCLUSIONS Moderate-quality evidence suggests that selective fetoscopic laser photocoagulation is not superior to amnioreduction in terms of decreasing perinatal or postnatal mortality of one or both twins as well. However, this technology has been associated to a decrease in the rate of neurological development abnormalities and a longer long-term survival. Moderate-quality evidence suggests that the Solomon technique is associated to a reduction in the anemia-polycythemia fetal sequence and in the recurrence of twin-twin transfusion syndrome when compared with selective fetoscopic laser photocoagulation. The clinical practice guidelines consulted recommend it as an alternative. Most of the coverage policies consulted from public and private sponsors from Europe and United States do not mention the technology; however some of them cover it. The Latin American public sponsors consulted do not cover or mention its coverage. No local cost-effectiveness, financial or organization impact studies have been found.
Details
Project Status: Completed
Year Published: 2018
URL for published report: https://www.iecs.org.ar/home-ets/
English language abstract: An English language summary is available
Publication Type: Not Assigned
Country: Argentina
MeSH Terms
  • Fetofetal Transfusion
  • Diseases in Twins
  • Laser Coagulation
  • Fetoscopy
Contact
Organisation Name: Institute for Clinical Effectiveness and Health Policy
Contact Address: Dr. Emilio Ravignani 2024, Buenos Aires - Argentina, C1414 CABA
Contact Name: info@iecs.org.ar
Contact Email: info@iecs.org.ar
Copyright: Institute for Clinical Effectiveness and Health Policy (IECS)
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.